• AVIA Names Linda Finkel as CEO

    Oct 23, 2020, 11:12 AM by Abhinav Singh
    CHICAGO, IL, UNITED STATES - Oct 23, 2020 - AVIA, the nation’s leading digital transformation partner for healthcare organizations, announced that its board of directors has appointed AVIA President Linda Finkel to also serve as chief executive officer, effective November 1, 2020
    Full story
  • BOC Sciences Lanuched A New Biotinylation Platform

    Oct 23, 2020, 00:05 AM by Abhinav Singh
    SHIRLEY, NY, UNITED STATES - Oct 23, 2020 - Recently, BOC Sciences, a New York-based chemical and pharmaceutical supplier, announced to launch a new biotinylation technology platform for the scientific community
    Full story
  • Profacgen Updated Its Pull Down Assay Service for Protein Interaction Study

    Oct 22, 2020, 09:32 AM by Abhinav Singh
    SHIRLEY, NY, UNITED STATES - Oct 22, 2020 - Profacgen, with an organized team of scientists with extensive experience in the study of protein-protein interaction, recently updated its pull down assay service to help efficiently and specifically verify the predicted protein-protein interactions or identify novel interactions
    Full story
  • Elsevier Signs Collaboration to Develop Novel Prediction Tool to Reduce Drug Development Safety Risk

    Oct 22, 2020, 05:16 AM by Abhinav Singh
    LONDON, UNITED KINGDOM - Oct 22, 2020 - Elsevier, a global information analytics business specializing in science and health, today announced its collaboration with the pharmaceutical company Novartis to develop a safety margin risk assessment prediction tool, largely using PharmaPendium data
    Full story
  • Aurinia Pharmaceuticals selects MyMeds&Me’s Reportum QuickStart platform to streamline drug safety reporting

    Oct 21, 2020, 15:04 PM by Abhinav Singh
    LONDON, UK - Oct 21, 2020 - MyMeds&Me, a leading provider of drug safety software to transform the end-to-end pharmacovigilance process, have today announced that Aurinia Pharmaceuticals Inc
    Full story
  • Alfa Chemistry Testing Lab Builds an Exclusive Regulatory Resource Section on Its Website

    Oct 21, 2020, 00:14 AM by Abhinav Singh
    NY, NY - Oct 21, 2020 - For customers who are not familiar with industry regulations, Alfa Chemistry Testing Lab has recently built an exclusive section of regulatory resource section for them on its website for reference purposes
    Full story
  • MDI Biological Laboratory Awarded $3.14 Million for Kidney Research

    Oct 20, 2020, 13:30 PM by Abhinav Singh
    BAR HARBOR, ME, UNITED STATES - Oct 20, 2020 - The MDI Biological Laboratory has announced that it has received a grant of $3.14 million over five years from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), an institute of the National Institutes of Health (NIH), for the development of artificial kidney tissue to replace human kidney tissue that is lost to disease or injury
    Full story
  • abeo Appoints Joe Ferro as Chief Technology and Innovation Officer

    Oct 20, 2020, 12:41 PM by Abhinav Singh
    DALLAS, TX, UNITED STATES - Oct 20, 2020 - abeo, a leader in physician-focused billing and practice management solutions, today announced its appointment of Joe Ferro to Chief Technology and Innovation Officer
    Full story
  • ATMPS advanced therapy blockchain platform has successful testing with NHS partners

    Oct 20, 2020, 12:31 PM by Abhinav Singh
    LONDON, UNITED KINGDOM - Oct 20, 2020 - : ATMPS Ltd – a spinout of FarmaTrust announces that its Hataali blockchain platform has been successfully tested with University Hospitals Birmingham NHS Foundation Trust’s system interface
    Full story
  • Optibrium Launches Cerella, a Novel Artificial Intelligence Platform for Active Learning in Drug Discovery

    Oct 20, 2020, 04:54 AM by Abhinav Singh
    CAMBRIDGE, UNITED KINGDOM - Oct 20, 2020 - Optibrium today announced the launch of Cerella, an Artificial Intelligence (AI) software platform for drug discovery that delivers active learning using advanced deep learning methods
    Full story
  • ‘High-Risk, High-Reward’ Approach To Finding Alzheimer’s Disease Treatments

    Oct 19, 2020, 18:45 PM by Michael Croft
    Bio-IT World The quest to find new medicines for Alzheimer’s disease (AD) may finally make some headway, thanks to a Target Enablement to Accelerate Therapy Development for Alzheimer’s Disease (TREAT-AD) project that is taking a “high-risk, high-reward” approach to diversifying the drug development pipeline, according to Lara Mangravite, president of Sage Bionetworks. The Seattle-based nonprofit is partnered with Emory University and the Structural Genomics Consortium (SGC) on the initiative.
    Full story
  • 908 Devices Announces New Additions to Its Executive Team

    Oct 16, 2020, 09:10 AM by Abhinav Singh
    BOSTON, MA, UNITED STATES - Oct 15, 2020 - 908 Devices, a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the appointment of two Vice Presidents to its executive team, including Maura Fitzpatrick as the Vice President of Product Management and Marketing; and Kevin McCallion as the Vice President of Production and New Product Introduction
    Full story
  • FOXP3 Protein Inhibited, Blocking Factor D Protein May Prevent Inflammatory Response, App Crowdsources Drug Candidates: COVID-19 Updates

    Oct 16, 2020, 01:20 AM by Michael Croft
    Bio-IT World I Cloud-based tool, IDseq, allows tracking of emerging pathogens, scientist who discovered SARS captures detailed look of immune system response to COVID-19, SARS-CoV-2 may become endemic, ORF3B identified as viral factor that impairs immune response, age is an independent factor to virus susceptibility, group of 80 researchers warns against herd immunity approach, high dose favipiravir had significant effect on preventing and treating virus in hamster model, REGN-COV2 antibody ‘cocktail’ offers protection in pre-clinical trial on macaques. Plus: SARS-CoV antibodies effectively neutralize SARS-CoV-2 infection in cultured cells, international open access database aims to reduce duplication of ongoing COVID-19 research and more.
    Full story
  • Bora Pharmaceuticals’ Bobby Sheng wins ‘CEO of the Year’ at CPhI Awards 2020

    Oct 15, 2020, 12:49 PM by Abhinav Singh
    - Oct 15, 2020 - Bora Pharmaceuticals, a full-service contract development and manufacturing organisation (CDMO) which specialises in immediate and modified-release tablets and capsules, along with serialised packaging, announced that its Chairman and CEO, Bobby Sheng, was unveiled as ‘CEO of the Year’ at the CPhI Pharma Awards 2020
    Full story
  • Dotmatics introduces Blueprint to provide self-service data analysis for medicinal and synthetic chemists

    Oct 15, 2020, 08:35 AM by Abhinav Singh
    BISHOP'S STORTFORD, UNITED KINGDOM - Oct 14, 2020 - Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced it has expanded its product portfolio to include Blueprint, a self-service, scientific visualization and analytics application for small molecule discovery
    Full story
  • Proving The Value Of Preventive Genomics

    Oct 15, 2020, 01:35 AM by Michael Croft
    Bio-IT World | The Bio-IT World Conference & Expo closed out with a plenary keynote presentation on preventive genomics by Robert Green, M.D., professor of medicine at Harvard Medical School and a physician-scientist who directs the G2P Research Program at Brigham and Women’s Hospital and the Broad Institute. Data-sharing difficulties were a recurring theme at this year’s conference but, as the COVID-19 Host Genetics Initiative has demonstrated, it is possible to combine genomic data to rapidly explore markers of disease, he says.
    Full story
  • AffaMed Therapeutics Announces Merger with EverInsight Therapeutics and Appoints Dayao Zhao, M.D., Ph.D. as CEO

    Oct 14, 2020, 15:50 PM by Abhinav Singh
    BELFORD, NJ, UNITED STATES - Oct 14, 2020 - SHANGHAI, China, Oct. 14, 2020 (GLOBE NEWSWIRE) -- AffaMed Therapeutics (“AffaMed”), a biopharmaceutical company focused on developing and commercializing transformative therapeutics to address ophthalmologic and central nervous system (CNS) disorders with high unmet medical need for patients in Greater China and beyond, today announced a definitive merger agreement with biopharmaceutical company EverInsight Therapeutics (“EverInsight”)
    Full story
  • Partek Genomic Analysis Software Reaches New Citation High: Over 8,000 Peer-reviewed Articles

    Oct 14, 2020, 14:29 PM by Abhinav Singh
    ST. LOUIS, MO, UNITED STATES - Oct 15, 2020 -   Partek Incorporated announced today that its software has been cited in over eight thousand peer-reviewed articles published in scientific journals, including the prestigious PNASCell, and Nature Medicine  journals
    Full story
  • New Healthcare Consumer Survey Shows Continued Rise in Demand for Digital Access and Catalytic Impact of the COVID-19 Pandemic

    Oct 14, 2020, 09:42 AM by Abhinav Singh
    BOSTON, MA, UNITED STATES - Oct 14, 2020 - Kyruus today announced findings from its fourth annual survey of 1,000 healthcare consumers exploring how they learn about, select, and schedule appointments with new providers
    Full story
  • Momentum for AVIA Members Strong as Digital Transformation Accelerates

    Oct 14, 2020, 09:34 AM by Abhinav Singh
    CHICAGO, MA, UNITED STATES - Oct 14, 2020 - While hospitals and health systems across the country face tremendous financial pressures and declining consumer confidence, AVIA Network Members continue to lead healthcare toward practical, impactful, and sustainable digital transformation
    Full story